Logo

The virtual summit on the use of AI technology in Oncology

Event Date: Wed, 28 Jan 2021
Event Location: Dubai
The AI in Oncology Summit will be focusing on the practical application and potential use of Artificial Intelligence (AI) in the therapeutic area of oncology. AI can provide a competitive edge by preserving and enhancing the value of the R&D pipeline through AI-based approaches. The summit will be held in a digital format and will explore how companies could improve their clinical development performance even in times of unprecedented challenges related to COVID-19.
trans-conference-2019

Speakers

Juergen Scheele SMD Senior Medical Director Prof. Dr. Dr. Juergen Scheele is the Global Clinical Development Lead for Tepotinib at Merck KGaA.
Andreas Penk Adv. Board, CancerCoin Dr. Andreas Penk is a member of the Advisory Board of CancerCoin
Oliver Eckelmann CEO, Discoveric Bio Oliver Eckelmann, PhD is an entrepreneur that is leading and involved in the founding of several Biotech companies.
Gunjan Bhardwaj CEO, Innoplexus Dr. Gunjan Bhardwaj is the Chief Executive Officer of the German Artificial Intelligence company Innoplexus AG.

Date, Schedule & Speakers

January 28, 2021, at 4 pm to 5.30 pm
TimeTopicSpeaker
16:00 – 16:10Introduction Greetings and a short summary of the story of and the tech behind InnoplexusGunjan Bhardwaj, Innoplexus
16:10 – 16:30Challenges in oncology drug development Learn more about how to handle opportunities and challenges in oncology drug development using a strategic approachJuergen Scheele, Merck
16:30 – 16:50Revolutionizing drug discovery with AI-powered target identification Find out how the Discoveric Bio Group augments their team of researchers with AI-driven analyticsOliver Eckelmann, Discoveric Bio Group
16:50 – 17:10Accelerating oncology research with blockchain CancerCoin is a new concept of using blockchain to improve the ability to bring oncology drugs safer to the marketAndreas Penk, CancerCoin
17:10 – 17:30Summary & closing remarks Wrap up of the summit and some sneak peeks on what next developments will happen in AI-powered oncology researchGunjan Bhardwaj, Innoplexus
DOWNLOAD AGENDA
speaker-icon
What’s New in Ontosight® Terminal 1 . 1

What’s New in Ontosight® Terminal 1 . 1

Read more
Partex Announces Strategic Collaboration with Shanghai Ark Biopharmaceutical forPartnership and Out-Licensing of AK0707

Partex Announces Strategic Collaboration with Shanghai Ark Biopharmaceutical forPartnership and Out-Licensing of AK0707

Read more
Partex and Singapore’s Experimental Drug Development Centre collaborate to bring forward an innovative approach for early drug discovery and development

Partex and Singapore’s Experimental Drug Development Centre collaborate to bring forward an innovative approach for early drug discovery and development

Read more
award

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More
ontosight ad illustration

Ontosight® Terminal

FREE for a limited time

Try now

We use first-party cookies to provide you the best possible experience. Necessary By clicking "Accept", you agree to the use of our cookies on your device.